• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of IFITM3 rs12252 Association with Severe Pediatric Influenza Infection

tetano

Editor, Senior Moderator
J Infect Dis. 2017 May 20. doi: 10.1093/infdis/jix242. [Epub ahead of print]
[h=1]Evaluation of IFITM3 rs12252 Association with Severe Pediatric Influenza Infection.[/h] Randolph AG[SUP]1[/SUP], Yip WK[SUP]2[/SUP], Allen EK[SUP]3[/SUP], Rosenberger CM[SUP]4[/SUP], Agan AA[SUP]5[/SUP], Ash SA[SUP]5[/SUP], Zhang Y[SUP]6[/SUP], Bhangale TR[SUP]7[/SUP], Finkelstein D[SUP]8[/SUP], Cvijanovich N[SUP]9[/SUP], Mourani PM[SUP]10[/SUP], Hall M[SUP]11[/SUP], Su HC[SUP]6[/SUP], Thomas PG[SUP]3[/SUP]; PALISI PICFLU Investigators.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background:[/h] Interferon inducible transmembrane protein 3 (IFITM3) restricts endocytic fusion of influenza virus. IFITM3 rs12252_C, a putative alternate splice site, has been associated with influenza severity in adults. IFITM3 has not been evaluated in pediatric influenza.
[h=4]Methods:[/h] The PICFLU Study enrolled children with suspected influenza infection across 38 pediatric intensive care units November 2008 to April 2016. IFITM3 was sequenced in patients and parents were genotyped for specific variants for family-based association testing. rs12252 was genotyped in 54 African-American pediatric outpatients with influenza (FLU09), included in the population-based comparisons with 1000 genomes. Splice site analysis of rs12252_C was performed using PICFLU and FLU09 patient RNA.
[h=4]Results:[/h] In PICFLU, 358 children had influenza infection. We identified two rs12252_C homozygotes in 185 white non-Hispanic children. rs12252_C was not associated with influenza infection in population or family-based analyses. We did not identify the Δ21 IFITM3 isoform in RNAseq data. rs12252 genotype was not associated with IFITM3 expression levels. rs12252 was not associated with critical illness severity. No novel rare IFITM3 functional variants were identified.
[h=4]Conclusions:[/h] rs12252 was not associated with susceptibility to influenza-related critical illness in children or with critical illness severity. Our data also do not support it being a splice site.


[h=4]KEYWORDS:[/h] IFITM3; Interferon inducible transmembrane protein; genetic susceptibility; influenza; pediatric

PMID: 28531322 DOI: 10.1093/infdis/jix242
 
Back
Top Bottom